About this trial
The IVUS CHIP UPP Registry is a prospective, observational, multicenter, single-arm registry. A total of 1010 patients with complex coronary lesions will be enrolled in up to 2 years, with at least 500 men and women. All patients will be treated with IVUS-guided PCI.
Eligibility criteria
Qualifiers
The patient must be ≥18 years of age and self-identify within a US census-defined minority
Angiographic heavy calcification
Ostial lesions
True bifurcation lesions involving side-branches >2.5mm
Disqualifiers
ST-elevation myocardial infarction or cardiogenic shock within prior 7 days
Known untreated severe valvular heart disease
Contraindication on the use of IVUS (i.e. extreme vessel tortuosity)
Requiring PCI in a diseased aorto-coronary bypass
Trial design
Treatments tested in this trial
- IVUS
Treatment groups
Locations
Sponsors and collaborators
ECRI bv
Lead sponsor
Boston Scientific Corporation
Collaborator
Cardialysis B.V.
Collaborator